Table 3 Secondary process measures and clinical outcomes pre-Intervention and during the study period

Last BP <130/80 mmHg

0.39 (0.33, 0.45)

0.41 (0.36, 0.46)

0.44 (0.38, 0.50)

0.44 (0.39, 0.49)

% of subjects with lab test in the last year

 Phosphorus

0.66 (0.60, 0.72)

0.70 (0.66, 0.75)

0.59 (0.53, 0.65)

0.75 (0.71, 0.79)*

 Urine protein

0.72 (0.67, 0.78)

0.72 (0.67, 0.76)

0.56 (0.50, 0.62)

0.63 (0.58, 0.68)*

 Hemoglobin

0.82 (0.76, 0.86)

0.80 (0.76, 0.84)

0.85 (0.80, 0.89)

0.84 (0.79, 0.87)

Subjects on a diuretic

0.71 (0.66, 0.76)

0.68 (0.63, 0.72)

0.77 (0.72, 0.81)

0.75 (0.71, 0.79)

Subjects on an ACEI/ARB

0.81 (0.76, 0.85)

0.75 (0.71, 0.79)*

0.77 (0.72, 0.82)

0.78 (0.74, 0.82)

Subjects with diabetes or proteinuria on an ACEI/ARB

0.89 (0.84, 0.93)

0.85 (0.80, 0.89)

0.86 (0.78, 0.91)

0.88 (0.83, 0.92)